These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11442880)
1. Alterations of nitric oxide and monoamines in the brain of the EL mouse treated with phenobarbital and zonisamide. Tominaga M; Nagatomo I; Uchida M; Hashiguchi W; Akasaki Y; Takigawa M Psychiatry Clin Neurosci; 2001 Aug; 55(4):311-8. PubMed ID: 11442880 [TBL] [Abstract][Full Text] [Related]
2. Influences of caffeine to nitric oxide production and zonisamide concentration in the brain of seizure-susceptible EL mice. Hashiguchi W; Nagatomo I; Akasaki Y; Uchida M; Tominaga M; Takigawa M Psychiatry Clin Neurosci; 2001 Aug; 55(4):319-24. PubMed ID: 11442881 [TBL] [Abstract][Full Text] [Related]
3. Effects of combined administration of zonisamide and valproic acid or phenytoin to nitric oxide production, monoamines and zonisamide concentrations in the brain of seizure-susceptible EL mice. Nagatomo I; Akasaki Y; Uchida M; Tominaga M; Hashiguchi W; Takigawa M Brain Res Bull; 2000 Sep; 53(2):211-8. PubMed ID: 11044598 [TBL] [Abstract][Full Text] [Related]
4. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model. Borowicz KK; Luszczki JJ; Sobieszek G; Ratnaraj N; Patsalos PN; Czuczwar SJ Eur Neuropsychopharmacol; 2007 Mar; 17(4):265-72. PubMed ID: 16876388 [TBL] [Abstract][Full Text] [Related]
5. Relationships between convulsive seizures and serum and brain concentrations of phenobarbital and zonisamide in mutant inbred strain EL mouse. Nagatomo I; Akasaki Y; Nagase F; Nomaguchi M; Takigawa M Brain Res; 1996 Aug; 731(1-2):190-8. PubMed ID: 8883869 [TBL] [Abstract][Full Text] [Related]
6. Zonisamide inhibits nitric oxide synthase activity induced by N-methyl-D-aspartate and buthionine sulfoximine in the rat hippocampus. Noda Y; Mori A; Packer L Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):23-33. PubMed ID: 10850366 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ Epilepsia; 2006 Nov; 47(11):1841-54. PubMed ID: 17116023 [TBL] [Abstract][Full Text] [Related]
8. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140 [TBL] [Abstract][Full Text] [Related]
9. Zonisamide: a new antiepileptic drug. Sobieszek G; Borowicz KK; Kimber-Trojnar Z; Małek R; Piskorska B; Czuczwar SJ Pol J Pharmacol; 2003; 55(5):683-9. PubMed ID: 14704463 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report. Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809 [TBL] [Abstract][Full Text] [Related]
11. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Bethmann K; Brandt C; Löscher W Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923 [TBL] [Abstract][Full Text] [Related]
12. Sequential changes of nitric oxide levels in the temporal lobes of kainic acid-treated mice following application of nitric oxide synthase inhibitors and phenobarbital. Kato N; Sato S; Yokoyama H; Kayama T; Yoshimura T Epilepsy Res; 2005 Jun; 65(1-2):81-91. PubMed ID: 15979286 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction of zonisamide in rats. Effect of zonisamide on other antiepileptics. Kimura M; Tanaka N; Kimura Y; Miyake K; Kitaura T; Fukuchi H Biol Pharm Bull; 1993 Jul; 16(7):722-5. PubMed ID: 8401412 [TBL] [Abstract][Full Text] [Related]
15. A prospective audit of adjunctive zonisamide in an everyday clinical setting. Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201 [TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322 [TBL] [Abstract][Full Text] [Related]
17. Effects of sodium nitroprusside, a nitric oxide donor, on gamma-aminobutyric acid concentration in the brain and on picrotoxin-induced convulsions in combination with phenobarbitone in rats. Paul V; Ekambaram P Pharmacol Biochem Behav; 2005 Mar; 80(3):363-70. PubMed ID: 15740777 [TBL] [Abstract][Full Text] [Related]
18. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Brandt C; Volk HA; Löscher W Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506 [TBL] [Abstract][Full Text] [Related]